Published in Immunol Today on October 01, 1991
Regulation of immune responses by prostaglandin E2. J Immunol (2012) 3.93
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut (1997) 2.35
Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med (1997) 2.14
Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol (1994) 2.08
Role of nitric oxide in parasitic infections. Microbiol Rev (1995) 1.91
Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis (2008) 1.76
IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med (2005) 1.76
Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg (2004) 1.65
Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med (1998) 1.62
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res (2008) 1.53
Subversion of host recognition and defense systems by Francisella spp. Microbiol Mol Biol Rev (2012) 1.40
Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev (2000) 1.39
Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism. J Exp Med (1994) 1.39
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology (2002) 1.36
Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase. Biochem J (1995) 1.36
RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34
Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A (1996) 1.33
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood (2010) 1.23
Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol (2005) 1.22
Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J Neurochem (1999) 1.19
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun (1993) 1.17
Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects. Clin Exp Immunol (1993) 1.16
Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology (2004) 1.10
Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells. J Immunol (2009) 1.05
Salmonella enterica serovar Typhimurium infection induces cyclooxygenase 2 expression in macrophages: involvement of Salmonella pathogenicity island 2. Infect Immun (2004) 1.01
Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol (1995) 1.00
Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun (2000) 1.00
Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun (2003) 0.99
Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid (2008) 0.99
Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus. Immunology (2006) 0.97
Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J Virol (2001) 0.97
PGE(2) suppression of innate immunity during mucosal bacterial infection. Front Cell Infect Microbiol (2013) 0.96
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol (2000) 0.95
Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology (1995) 0.95
Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect Immun (1995) 0.93
Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J Immunol (2008) 0.92
Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis. Mediators Inflamm (2012) 0.91
Regulation of the Stem Cell-Host Immune System Interplay Using Hydrogel Coencapsulation System with an Anti-Inflammatory Drug. Adv Funct Mater (2015) 0.91
Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cell Mol Immunol (2013) 0.90
Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun (1997) 0.89
Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice. Hepatology (2013) 0.89
Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J (2002) 0.89
Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats. Inflammopharmacology (2005) 0.88
Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J Clin Invest (1997) 0.88
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol (2000) 0.88
Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int (2015) 0.86
The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease. Mediators Inflamm (2013) 0.86
Staphylococcal glycocalyx activates macrophage prostaglandin E2 and interleukin 1 production and modulates tumor necrosis factor alpha and nitric oxide production. Infect Immun (1994) 0.85
Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS One (2009) 0.84
T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol (2003) 0.84
Characterization of prostanoid receptors on rat neutrophils. Br J Pharmacol (1994) 0.84
An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun (1997) 0.83
Interleukin-4 inhibits cyclo-oxygenase-2 expression and prostaglandin E production by human mature dendritic cells. Immunology (2006) 0.81
Modulation of retinal Müller cells by complement receptor C5aR. Invest Ophthalmol Vis Sci (2013) 0.81
How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review. Apoptosis (2015) 0.81
Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). Clin Exp Immunol (1999) 0.80
The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. Biomed Res Int (2013) 0.80
Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus. J Gastroenterol (2005) 0.79
Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm (2013) 0.78
Pancreatic cancer cell lines can induce prostaglandin e2 production from human blood mononuclear cells. J Oncol (2011) 0.78
Immunoregulatory activities of eicosanoids in the rainbow trout (Oncorhynchus mykiss). Immunology (1995) 0.78
Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis. Immunology (2001) 0.78
Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae. Pharmacogn Mag (2016) 0.77
Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections. Infect Immun (2002) 0.77
Anti-inflammatory activity of Nerium indicum by inhibition of prostaglandin E2 in murine splenic lymphocytes. Indian J Pharmacol (2015) 0.77
Modulatory effect of mycobacterium cell wall extract (Regressin) on lymphocyte blastogenic activity and macrophage cytokine gene transcription in swine. Clin Diagn Lab Immunol (1997) 0.77
Dendritic cell differentiation with prostaglandin E results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production. Immunology (2010) 0.77
Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units. Front Immunol (2016) 0.77
Cloning and expression of prostaglandin E2 receptor subtype 1 (ep 1 ) in Bostrichthys sinensis. Fish Physiol Biochem (2014) 0.76
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio (2017) 0.75
Besnoitia besnoiti infections activate primary bovine endothelial cells and promote PMN adhesion and NET formation under physiological flow condition. Parasitol Res (2016) 0.75
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs. Biomed Res Int (2016) 0.75
Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus. Virology (2012) 0.75
Cell-based screening identifies the active ingredients from Traditional Chinese Medicine formula Shixiao San as the inhibitors of atherosclerotic endothelial dysfunction. PLoS One (2015) 0.75
Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy. Br J Cancer (1996) 0.75
Effect of antipyretic analgesics on immune responses to vaccination. Hum Vaccin Immunother (2016) 0.75
Prostaglandin E2 As a Modulator of Viral Infections. Front Physiol (2017) 0.75
Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J (1997) 2.49
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens. Ann Oncol (2009) 1.89
Complete coding sequences of the rabbitpox virus genome. J Gen Virol (2005) 1.04
Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol (2001) 0.92
Examiner reliability for an invasive gingival bleeding index. J Clin Periodontol (1992) 0.90
Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains. Cell Immunol (1987) 0.86
Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells. Immunol Rev (1990) 0.84
A dynamic model of regional population growth and decline. J Reg Sci (1988) 0.84
A relationship between proteinase activity and clinical parameters in the treatment of periodontal disease. J Clin Periodontol (1998) 0.82
Comparison between mechanical cleaning and an antimicrobial rinse for the treatment and prevention of interdental gingivitis. J Clin Periodontol (1993) 0.81
Myelolipoma arising from ectopic adrenal cortex: case report and review of the literature. Am J Gastroenterol (1986) 0.81
A single-center experience of preemptive anticoagulation for patients with risk factors for allograft thrombosis in renal transplantation. Clin Nephrol (2010) 0.80
Prostaglandin E2 regulates gingival mononuclear cell immunoglobulin production. J Periodontol (1995) 0.77
Amphotericin B selectively stimulates macrophages from high responder mouse strains. Immunopharmacol Immunotoxicol (1991) 0.77
HLA-DR alleles are associated with IDDM, but not with impaired neutrophil chemotaxis in IDDM. J Dent Res (1998) 0.75
Alternative antigen presentation pathways: accessory cells which down-regulate immune responses. Reg Immunol (1990) 0.75
Bonding attachments directly to teeth. JPO J Pract Orthod (1969) 0.75
A dynamic interregional theory of migration and population growth. Land Econ (1991) 0.75
Arousal level in repressors and sensitizers as a function of response context. J Consult Clin Psychol (1971) 0.75
They labeled me a "questionable doctor"--and I fought like hell to clear my name. Med Econ (2000) 0.75
The semantics of "Doctor-Dentist" and other symbolic language. N Y J Dent (1973) 0.75
Conscious and preconscious influences on recall: a reassessment and extension. Psychol Rep (1967) 0.75
Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts. J Clin Periodontol (1996) 0.75
Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinoma. Am J Clin Oncol (1985) 0.75
The importance of different murine cell types in the immunopotentiation produced by amphotericin methyl ester. Cell Immunol (1978) 0.75